Results 131 to 140 of about 23,997 (201)

Dystrophic Epidermolysis Bullosa

, 2018
Epidermolysis bullosa is a rare inherited blistering disease with an incidence of 8-10 per million live births. Dystrophic epidermolysis bullosa is a type of epidermolysis bullosa caused by mutation in type VII collagen, COL7A1.
Shumneva Shrestha, Sanjay Kumar Gupta, Randhir Sagar Yadav, Upama Paudel, Amar Jayswal   +4 more
core   +1 more source

Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagen

, 2002
We describe a 73-year-old patient who had a subepidermal bullous eruption develop after a course of antibiotics, including vancomycin. The patient had deposits of IgA and IgG in the cutaneous basement membrane zone that were located on the dermal side of
Borradori, Luca, Friedli, André, Prins, Christa, Woodley, David T, Desmeules, Jules Alexandre, Saurat, Jean-Hilaire, Delbaldo, Catherine Suzanne, Chen, Meilin   +7 more
core  

Dystrophic epidermolysis bullosa: a review

, 2015
Satoru Shinkuma Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan Abstract: Dystrophic epidermolysis bullosa is a rare inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII ...
Shinkuma S
core  

Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins

, 2002
Epidermolysis bullosa acquisita (EBA) is a rare autoimmune bullous disorder that is often difficult to treat. Few cases have been reported and therapy consists mainly of combinations of systemic steroids, immunosuppressants and, recently, administration ...
Nicolaidou, E, Aroni, K, Gourgiotou, K, Paraskevakou, H, Katsambas, AD, Exadaktylou, D, Rallis, E   +6 more
core   +1 more source

Case report: A case of epidermolysis bullosa acquisita with IgG and IgM anti-basement membrane zone antibodies relapsed after COVID-19 mRNA vaccination. [PDF]

Front Med (Lausanne), 2023
Minakawa S, Matsuzaki Y, Yao S, Sagara C, Akasaka E, Koga H, Ishii N, Hashimoto T, Sawamura D.   +8 more
europepmc   +1 more source

Vesiculobullous Erythema Elevatum Diutinum: a Rare Variant With Epidermolysis Bullosa Acquisita-like Immunofluorescence Findings. [PDF]

Dermatol Pract Concept, 2022
Yalici-Armagan B, Ates-Ozdemir D, Yeter G, Atakan N.   +3 more
europepmc   +1 more source

Cochrane Library: Interventions for Mucous Membrane Pemphigoid and Epidermolysis Bullosa Acquisita.

Journal of American Academy of Dermatology, 2022
Kathryn A Sprague, T. Sivesind, M. Szeto, R. Dellavalle, G. Kirtschig   +4 more
semanticscholar   +1 more source

Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita. [PDF]

Front Immunol, 2022
Haeger SC, Kridin K, Pieper M, Griewahn L, Nimmerjahn F, Zillikens D, König P, Ludwig RJ, Hundt JE.   +8 more
europepmc   +1 more source

Treatment of Epidermolysis bullosa acquisita with dupilumab

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Rebecca Diehl, D. Kiritsi, Franziska Schauer   +2 more
semanticscholar   +1 more source

Epidermolysis bullosa acquisita improved with use of dupilumab. [PDF]

JAAD Case Rep
Raneses E, Nolan CF, Schmiedecke RF, Lyford WH.   +3 more
europepmc   +1 more source